Canopy Growth (NASDAQ: CGC) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions. It recently secured renewed European Union manufacturing certifications for multiple Canadian facilities to support its supply chain, and it expanded its international medical cannabis operations by launching new product formats in Australia, supplying four Canadian-grown flower strains to the United Kingdom, and appointing a dedicated country manager for it.
POLARIS INSIGHTS